"10.1371_journal.pone.0051633","plos one","2012-12-07T00:00:00Z","Xianfeng Zhang; Tomoyoshi Sobue; Mao Isshiki; Shun-ichi Makino; Makoto Inoue; Kazunori Kato; Tatsuo Shioda; Takashi Ohashi; Hirotaka Sato; Jun Komano; Hideji Hanabusa; Hisatoshi Shida","Institute for Genetic Medicine, Hokkaido University, Kita-ku, Sapporo, Japan; DNAVEC Corporation, Techno Park Oho, Tsukuba, Ibaraki, Japan; Department of BioMedical Engineering, Toyo University, Kawagoe, Saitama, Japan; Department of Viral Infection, Research Institute for Microbial Disease, Osaka University, Yamada-oka, Suita-shi, Osaka, Japan; Division of Virology, Department of Infectious Diseases, Osaka Prefectural Institute of Public Health, Nakamichi Higashinari-ku, Osaka, Japan; Ogikubo Hospital, Ogikubo, Suginami, Tokyo, Japan","Conceived and designed the experiments: XZ H. Shida. Performed the experiments: XZ T. Sobue M. Isshiki SM H. Sato. Analyzed the data: XZ T. Sobue M. Isshiki SM H. Shida. Contributed reagents/materials/analysis tools: M. Inoue KK T. Shioda TO JK HH. Wrote the paper: XZ H. Shida.","The authors declare one author, M. Inoue, has an affiliation in DNAVEC Corporation. Although DNAVEC, a profit company, has developed and is preparing for marketing the Sendai Virus Vector (SeV Vector), it has not financially supported this study at all. This study has been exclusively supported by the grants (No: 21390135) of Ministry of Education, Culture, Sports, Science and Technology and that (No: SAB4861) of Human Health Foundation. Thus, participation of Makoto Inoue, a member of DNAVEC, does not alter the authors adherence to all the PLOS ONE policies on sharing data and materials.","2012","12","Xianfeng Zhang","XZ",12,TRUE,2,2,2,2,TRUE,TRUE,TRUE,2,"6;10",TRUE
